WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tango Therapeutics revenue was $40.99M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $5.4M, up 31% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNGX annual revenue was $42.1M, with 15.2% growth year-over-year.

TNGX past revenue growth

How has TNGX's revenue growth performed historically?

Company
10.1%
Industry
1,361.15%
Market
34.96%
TNGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TNGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TNGX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TNGX revenue history

Current Revenue
$41.0M
Current Earnings
-$132.3M
Current Profit Margin
-322.7%

Be the first to know when TNGX announces revenue.

TNGX Revenue History By Year

TNGX Yearly RevenueTNGX RevenueTNGX ChangeTNGX Revenue Growth
2024-12-31$42.07M$5.54M+15.17%
2023-12-31$36.53M$11.67M+46.93%
2022-12-31$24.86M-$12.18M-32.89%
2021-12-31$37.04M$29.39M+383.83%
2020-12-31$7.66M-$16.99M-68.94%
2019-12-31$24.65MN/AN/A

1 of 1

Tango Therapeutics Revenue FAQ

What was TNGX's revenue last quarter?

On Invalid Date, Tango Therapeutics (NASDAQ: TNGX) reported Q1 2025 revenue of $5.39 million up 16.67% year over year. In the same quarter last year, Tango Therapeutics's revenue was $6.47 million.

What was Tango Therapeutics's revenue in 2024?

Tango Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $42.07 million, a 15.17% increase year over year.

How much does Tango Therapeutics make in a day?

Based on Tango Therapeutics annual revenue for the past five years, TNGX makes an average of $81,180.27 per day.

What was Tango Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Tango Therapeutics's revenue has grown 10.1% year over year. This is 1,351.05 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Tango Therapeutics's revenue in the past year totaled $40.99 million.

How much does Tango Therapeutics make in a year?

Tango Therapeutics's revenue by year for the past five years is:
  • Tango Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $42.07 million, a 15.17% increase year over year.
  • Tango Therapeutics's annual revenue for Dec 31, 2023 was $36.53 million, a 46.93% increase from 2022.
  • Tango Therapeutics's annual revenue for 2022 was $24.86 million, a 32.89% decrease from 2021.
  • Tango Therapeutics's annual revenue for 2021 was $37.04 million, a 383.83% increase from 2020.
  • Tango Therapeutics's annual revenue for 2020 was $7.66 million, a 68.94% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.